Market Access and Value Strategy

Market access requires understanding how decision-makers value and prioritize resources in clinical practice, and integrating clinical, economic, and contextual evidence to support informed and strategic health decisions.

When is a value strategy needed?

  • When a decision regarding access or coverage needs to be justified
  • When the price does not reflect the clinical and economic value
  • When budget constraints exist
  • When it is necessary to align evidence with the decision-maker’s language

What we do in Market Access and Value Strategy

  • Building value stories
    Value narratives based on clinical and economic evidence.
  • Developing value arguments
    Integrating clinical, economic, and contextual outcomes.
  • Providing analytical support for access and negotiation processes
    Technical support in interactions with payers and decision-makers.
  • Adapting evidence to the local context
    Adjusting messages and analyses for specific healthcare systems.

Strategic approach

Our approach combines analytical rigor with an understanding of the decision-making process. The value strategy is built based on the decision-maker, the context, and the moment, ensuring clear, consistent, and defensible messages.

What the customer gets

  • Clear and coherent value propositions
  • Messaging aligned with decision-making
  • Technical support for discussions with third payers
  • Effective integration of clinical and economic evidence

Who is it for?

  • Pharmaceutical and biotechnology industry
  • Market access and pricing teams
  • Organizations that interact with payers

Do you need to translate evidence into access and value decisions?

Let's talk about your project.

Request a meeting
Send us a message

You can use this form to send us a message and arrange a conversation

Puede utilizar este formulario para enviarnos un mensaje y coordinar una conversación.